Novartis Venture Fund
General contacts
Investor type
CVC / VC
Founded
1996
AUM
$750 M
Location
Basel, Basel-Stadt, Switzerland
Investor profile last updated: 15 May, 2025
Profile
Investment Focus:
Our primary focus is on the development of novel therapeutics and platforms. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capital efficiency in the program.
Invest Globally:
We invest in North America, Europe and Israel with approximately USD 750 million under management in committed capital and more than 24 portfolio companies. We continue our strategy of making larger focused investments and anticipate total investments up to USD 30 million per company over its life.
Invest Across Healthcare Sector:
We make equity investments in Biotechnology/Biopharma life sciences companies. NVF is stage agnostic and engages in seed investments as well as later-stage investments. We typically lead or co-lead an investment and play an active role on company boards.
Industry
Novartis Venture Fund Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Novartis Korea Venture Fund
|
Fund of funds
|
Biotechnology
Pharmaceuticals
Life Sciences
HealthTech
|
Seed
Series A
Series B
Late Stage (Series C+)
|
North America
Europe
|
$5-10 m
|
$20 M
|
January 2008
|
|
Novartis Option Fund
|
Fund of funds
|
Biotechnology
Pharmaceuticals
Life Sciences
HealthTech
|
Seed
Series A
Series B
Late Stage (Series C+)
|
North America
Europe
|
$5-10 m
|
$200 M
|
January 2009
|
Contacts
Name
Title
Email
Social Networks
Investment-team contacts for Novartis Venture Fund — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
FAQs about Novartis Venture Fund
Is Novartis Venture Fund a venture capital or private equity firm?
Novartis Venture Fund is a venture capital firm that also operates as a corporate VC (CVC). It backs companies at Seed, Series B and Series A, writing tickets of $1-5 m.
Where is Novartis Venture Fund located?
Novartis Venture Fund is located in Basel, Basel-Stadt, Switzerland.
When was Novartis Venture Fund founded?
Novartis Venture Fund was founded in 1996.
What sectors and industries does Novartis Venture Fund invest in?
Novartis Venture Fund invests in companies and startups in Healthcare Services, Biotechnology, Software, Life Sciences, HealthTech, Digital, Pharmaceuticals, MedTech, Technology.
What is Novartis Venture Fund geographical focus of investments?
Novartis Venture Fund invests in companies and startups in North America, Europe.
At what stages of companies and startups does Novartis Venture Fund typically invest in?
Novartis Venture Fund invests in companies and startups at Seed, Series B, Series A.
What is the usual amount of Novartis Venture Fund investment?
Novartis Venture Fund usually invests $1-5 m on average.
What is the amount of assets of under management (AUM) for Novartis Venture Fund?
Novartis Venture Fund has around $750m assets under management.
When was Novartis Venture Fund last fund created?
Novartis Venture Fund last fund was created/launched in 2009-01-16
Is Novartis Venture Fund impact investor?
Yes, Novartis Venture Fund is impact investor.
What are the contacts of Novartis Venture Fund?
Novartis Venture Fund can be reached through its website nvfund.com, its LinkedIn page and its X account. Its general enquiries address is info.nvf@nvfund.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Novartis Venture Fund — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Can I access Novartis Venture Fund data via API or MCP?
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Novartis Venture Fund directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
When was the Novartis Venture Fund profile last updated?
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 15 May, 2025. Something out of date here? Report it — we re-run that firm within 48h and get back to you.